What is the purpose of registration submission guide, based on data from scientific literature?

The economic impact of the new health technologies

Unraveling the Abbreviated Development Path

What are the new expectations for the development of incremental products and medicines?

COVID-19: What facilities is ANVISA providing at this time of crisis?

API, BPF and drug dossier - How to align the processes to ensure success in registration?

NEW API REGULATORY FRAMEWORK: Will ANVISA and international manufacturers be prepared?

Publication of the new API regulatory framework: what is essential to know?

What is important about the new regulatory framework for good manufacturing practices?